BACKGROUND: Our previous reports suggested a possible association between parvovirus B19 (B19V) infection and systemic sclerosis (SSc), based on higher prevalence of B19V DNA in SSc patients in respect to controls.METHODS: In the present study, to further evaluate the differences in the pattern of B19 infection in SSc, skin biopsies and bone marrow samples from patients and controls were analysed for B19V DNA detection, genotyping and viral expression.RESULTS: B19V DNA was detected in skin biopsies from 39/49 SSc patients and from 20/28 controls. Bone marrow showed positive in 17/29 SSc patients, 5/21 haematological patients and 0/10 healthy controls. Genotype 1 was more frequent in skin and bone marrow from patients than from controls. Simultaneous persistence of 2 genotypes was detected in SSc skin and bone marrow samples, never in controls. Viral mRNA for capsid protein was detected in the skin of genotype 1-positive patients and not in control skins.CONCLUSION: The results outline some differences in the rate of persistence of B19V DNA, in the simultaneous persistence of 2 genotypes and in the pattern of viral expression among SSc patients and controls.

Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients / Zakrzewska, K; Corcioli, F; Carlsen, Km; Giuggioli, D; Fanci, R; Rinieri, A; Ferri, Clodoveo; Azzi, A.. - In: INTERVIROLOGY. - ISSN 0300-5526. - STAMPA. - 52:(2009), pp. 279-282.

Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients

Giuggioli D;FERRI, Clodoveo;
2009

Abstract

BACKGROUND: Our previous reports suggested a possible association between parvovirus B19 (B19V) infection and systemic sclerosis (SSc), based on higher prevalence of B19V DNA in SSc patients in respect to controls.METHODS: In the present study, to further evaluate the differences in the pattern of B19 infection in SSc, skin biopsies and bone marrow samples from patients and controls were analysed for B19V DNA detection, genotyping and viral expression.RESULTS: B19V DNA was detected in skin biopsies from 39/49 SSc patients and from 20/28 controls. Bone marrow showed positive in 17/29 SSc patients, 5/21 haematological patients and 0/10 healthy controls. Genotype 1 was more frequent in skin and bone marrow from patients than from controls. Simultaneous persistence of 2 genotypes was detected in SSc skin and bone marrow samples, never in controls. Viral mRNA for capsid protein was detected in the skin of genotype 1-positive patients and not in control skins.CONCLUSION: The results outline some differences in the rate of persistence of B19V DNA, in the simultaneous persistence of 2 genotypes and in the pattern of viral expression among SSc patients and controls.
52
279
282
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients / Zakrzewska, K; Corcioli, F; Carlsen, Km; Giuggioli, D; Fanci, R; Rinieri, A; Ferri, Clodoveo; Azzi, A.. - In: INTERVIROLOGY. - ISSN 0300-5526. - STAMPA. - 52:(2009), pp. 279-282.
Zakrzewska, K; Corcioli, F; Carlsen, Km; Giuggioli, D; Fanci, R; Rinieri, A; Ferri, Clodoveo; Azzi, A.
File in questo prodotto:
File Dimensione Formato  
intervirology.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 93.96 kB
Formato Adobe PDF
93.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/646414
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 26
social impact